MGI Tech Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005PC8
CNY
57.98
-4.21 (-6.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of -8.55% and Operating profit at -215.62% over the last 5 years

 
2

Risky -

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 13,915 Million (Large Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.28

stock-summary
Return on Equity

-3.40%

stock-summary
Price to Book

1.80

Revenue and Profits:
Net Sales:
755 Million
(Quarterly Results - Sep 2025)
Net Profit:
-16 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.32%
0%
-6.32%
6 Months
-14.34%
0%
-14.34%
1 Year
-28.47%
0%
-28.47%
2 Years
-15.92%
0%
-15.92%
3 Years
-44.15%
0%
-44.15%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

MGI Tech Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-8.55%
EBIT Growth (5y)
-215.62%
EBIT to Interest (avg)
-46.81
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.35
Sales to Capital Employed (avg)
0.33
Tax Ratio
8.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
5.52%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.61
EV to EBIT
-41.66
EV to EBITDA
-190.55
EV to Capital Employed
4.94
EV to Sales
8.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-11.87%
ROE (Latest)
-5.32%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 14.46% vs -13.23% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 90.09% vs -63.86% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "755.20",
          "val2": "659.80",
          "chgp": "14.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.80",
          "val2": "-79.30",
          "chgp": "102.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.60",
          "val2": "7.50",
          "chgp": "1.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-16.40",
          "val2": "-165.50",
          "chgp": "90.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.40%",
          "val2": "-293.70%",
          "chgp": "29.61%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 3.48% vs -31.05% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -0.30% vs -130.01% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,003.90",
          "val2": "2,903.00",
          "chgp": "3.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-200.40",
          "val2": "-497.10",
          "chgp": "59.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "25.90",
          "val2": "15.30",
          "chgp": "69.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.60",
          "val2": "14.10",
          "chgp": "-160.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-609.00",
          "val2": "-607.20",
          "chgp": "-0.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-199.00%",
          "val2": "-287.90%",
          "chgp": "8.89%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
755.20
659.80
14.46%
Operating Profit (PBDIT) excl Other Income
1.80
-79.30
102.27%
Interest
7.60
7.50
1.33%
Exceptional Items
0.10
0.00
Consolidate Net Profit
-16.40
-165.50
90.09%
Operating Profit Margin (Excl OI)
2.40%
-293.70%
29.61%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 14.46% vs -13.23% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 90.09% vs -63.86% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
3,003.90
2,903.00
3.48%
Operating Profit (PBDIT) excl Other Income
-200.40
-497.10
59.69%
Interest
25.90
15.30
69.28%
Exceptional Items
-8.60
14.10
-160.99%
Consolidate Net Profit
-609.00
-607.20
-0.30%
Operating Profit Margin (Excl OI)
-199.00%
-287.90%
8.89%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 3.48% vs -31.05% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -0.30% vs -130.01% in Dec 2023

stock-summaryCompany CV
About MGI Tech Co., Ltd. stock-summary
stock-summary
MGI Tech Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available